Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana
Sponsor: Centre Hospitalier Universitaire de la Réunion
Summary
In the context of the ongoing chikungunya epidemic in Réunion Island and the anticipated epidemic in French Guiana, the investigators propose an ambispective study to evaluate the real-world effectiveness, safety, and immunogenicity of the recommended vaccines, IXCHIQ® and VIMKUNYA®, as defined by the French National Authority for Health (HAS).
Official title: Real-world Effectiveness, Safety, and Immunogenicity of Chikungunya Vaccination During an Epidemic Period: an Ambispective Study in Réunion Island and French Guiana.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1505
Start Date
2025-04-18
Completion Date
2027-12
Last Updated
2026-09-28
Healthy Volunteers
No
Conditions
Interventions
IXCHIQ
Group of vaccinated arm will be with the IXCHIQ vaccine
VIMKUNYA
Other group of vaccinated arm will be with the VIMKUNYA vaccine
Locations (2)
Centre Hospitalier Universitaire de Guyane
Cayenne, French Guiana
Centre Hospitalier Universitaire de La Réunion
Saint-Denis, Reunion